title: Rho kinase inhibition and vascular protection: support from studies in Bartter and Gitelman syndrome.
authors.forename: Lorenzo A
authors.initials: LA
authors.lastname: Calò
authors.forename: Elisa
authors.initials: E
authors.lastname: Pagnin
authors.forename: Paul A
authors.initials: PA
authors.lastname: Davis
authors.forename: Michelangelo
authors.initials: M
authors.lastname: Sartori
authors.forename: Andrea
authors.initials: A
authors.lastname: Semplicini
authors.forename: Achille C
authors.initials: AC
authors.lastname: Pessina
mesh_terms: D001477:Bartter Syndrome / Q000188:drug therapy*; D004791:Enzyme Inhibitors / Q000627:therapeutic use*; D006801:Humans; D047908:Intracellular Signaling Peptides and Proteins; D019001:Nitric Oxide Synthase / Q000235:genetics*; D052250:Nitric Oxide Synthase Type III; D017346:Protein Serine-Threonine Kinases / Q000037:antagonists & inhibitors*; D054460:rho-Associated Kinases
chemical_list: D004791:Enzyme Inhibitors; D047908:Intracellular Signaling Peptides and Proteins; C496314:NOS3 protein, human; D019001:Nitric Oxide Synthase; D052250:Nitric Oxide Synthase Type III; D017346:Protein Serine-Threonine Kinases; D054460:rho-Associated Kinases